American Society of Hirudotherapy

Modified method of scalp fixation promotes survival of complete scalp avulsion replantation

Case report published in Clin Case Rep (2024)

Last Updated: June 18, 2026Reviewed by: ASH Editorial Board
Research article — evidence reviewArticle reference
Evidence: Research reportClinical TrialsXu et al. · Clinical case reports, 2024

Abstract

A complete scalp avulsion injury is rare but extremely challenging to treat. Because of the dense blood vessel bundles in the scalp, replantation failure may occur if there is a subcutaneous hematoma. The method of scalp fixation is crucial for replantation to be successful. We successfully treated a total scalp avulsion injury using a modified scalp fixation method, coupled with microsurgical anastomosis, to avoid subcutaneous hematoma effectively and achieved a satisfactory outcome with a follow-up of 9 years postoperatively.

Abstract sourced from PubMed (NCBI) for the cited record. See the original publication for the authoritative version.

Publication typeJournal Article

Summary

Modified scalp-fixation technique promoting survival of complete scalp-avulsion replantation.

Why This Matters for Hirudotherapy

This article reports successful complete scalp avulsion replantation using a modified scalp fixation method combined with microsurgical anastomosis, aimed at preventing subcutaneous hematoma, with satisfactory outcomes at 9-year follow-up. While scalp replantation and microsurgical reconstruction are clinical contexts where leech therapy has occasionally been used for venous congestion management, this abstract makes no mention of leeches, hirudotherapy, or any leech-derived intervention. The study is a single case report focused on a technical modification of scalp fixation to avoid hematoma formation. No defensible connection to leech therapy, the leech secretome, or hirudin-based anticoagulation can be drawn from the abstract provided.

Citation

Modified method of scalp fixation promotes survival of complete scalp avulsion replantation.

Xu et al. · Clinical case reports, 2024

Added to ASH library: May 27, 2026 · Site last updated: June 18, 2026

This website provides educational information and does not constitute medical advice, diagnosis, or treatment recommendations. Medicinal leech therapy carries clinically meaningful risks and should be performed only by qualified clinicians under institutionally approved protocols. FDA 510(k) clearance for medicinal leeches is limited to specific indications; investigational and off-label discussions are labeled accordingly. For patient-specific guidance, consult a qualified healthcare provider.